Prof. Dr. Hanno Steen profile page

Hanno Steen, PhD, is an Associate Professor of Pathology at Harvard Medical School, Principal Investigator in the Department of Pathology at Boston Children’s Hospital (BCH) and its Director of Proteomics. He is a member of the Neurobiology Program at BCH, the Precision Vaccines Program at BCH, the NIAID-funded Human Immunology Project Consortium (HIPC), Immune Development in Early Life (IDEaL) and Immunophenotyping Assessment in a Covid-19 Cohort (IMPACC) programs, and the NCI/NIDDK-funded Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC) consortium. After studying chemistry in Freiburg/Germany, Manchester/UK (UMIST) and Zurich/Switzerland (ETH), he received his Ph.D. from the University of Southern Denmark (Odense/Denmark) under the supervision of Dr. Matthias Mann. After postdoctoral training in proteomics and quantitative biology in the laboratories of Drs. Steve Gygi and Marc Kirschner at Harvard Medical School, he joined the faculty at Harvard Medical School and BCH in 2004. At BCH, he established a state-of-the-art proteomics laboratory dedicated to developing and applying quantitative proteomics methods to identify disease-relevant biomarkers in primary human specimens. His laboratory is currently focused on developing high-throughput and sample proteomics methods for detecting biomarkers in small amounts of systemic body fluids such as urine or blood for various inflammatory, infectious and neurodegenerative diseases. He has published more than 180 papers in international peer-reviewed (https://pubmed.ncbi.nlm.nih.gov/?term=steen+hanno; https://scholar.google.com/scholar?hl=en&as_sdt=0%2C22&q=hanno+steen&oq=), which have been cited more than 24,000 times, resulting in an h-index of 67.